Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Spiriva Respimat
Generic name / active ingredient
tiotropium bromide inhalation spray
Dosage-form class
SPIRIVA RESPIMAT metered inhalation spray: 1.25 mcg or 2.5 mcg per labelled actuation; dedicated inhaler-and-cartridge system (as listed in DailyMed SPL v16)
Route
Oral inhalation
Record reviewed
2026-08-22

Copy from the pack in hand

Source-linked reading points

  • “1.25 mcg / 2.5 mcg per actuation” is a label-identity field for one actuation from this spray device, not a webpage answer to how many times anyone should use it in a day. Check the exact product name, cap colour, NDC, inhaler, cartridge, target market and prescription label together.
  • The label says the cartridge is only for the SPIRIVA RESPIMAT inhaler and is not to be interchanged with another RESPIMAT device product. Similar device names, a shared ingredient, both saying “inhalation,” or the same brand family do not establish self-interchangeability of a device, cartridge or strength.
  • SPIRIVA HANDIHALER is an inhalation-powder capsule with a HandiHaler device; RESPIMAT is a spray inhaler with a cartridge. A HandiHaler “18 mcg capsule” is neither a RESPIMAT cartridge nor a swallowed capsule, and a shared generic name or microgram number does not establish a switch.
  • The label distinguishes this product from immediate relief of acute bronchospasm. Sudden or worsening breathlessness, wheeze, chest tightness or uncertainty about the device needs local urgent-care pathways and an existing care plan, with the actual device and full medicine list reviewed by a pharmacist or clinician.

Reviewed presentation examples — compare every field

  • Tiotropium 1.25 mcg per labelled actuation; one RESPIMAT inhaler plus one dedicated cartridge (60 labelled actuations)NDC 0597-0160-61
  • Tiotropium 2.5 mcg per labelled actuation; one RESPIMAT inhaler plus one dedicated cartridge (60 labelled actuations)NDC 0597-0100-61

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-22
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image